Torin2相关论文
Torin2 overcomes sorafenib resistance via suppressing mTORC2-AKT-BAD pathway in hepatocellular carci
Background: Sorafenib is an oral multi-kinase inhibitor that was approved by the US Food and Drug Administration for the......
